Bad Precedent? Plan B Dual Labeling Could Impact Existing OTCs – NEJM
This article was originally published in The Tan Sheet
Executive Summary
Dual Rx/OTC labeling for the Plan B emergency contraceptive may have similar implications for medications that are already available over the counter, according to an editorial in the June 3 New England Journal of Medicine